In addition, 8-OHD induces degradation of BCR-ABL oncoprotein and promotes early growth response 1 (EGR1)-mediated megakaryocyte differentiation, which could be a potential compound for the treatment of CML [62,63]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.